Enrollment is underway in a Phase 3 clinical trial testing the investigational therapy pegcetacoplan in adults with primary cold…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
Signs of cold agglutinin disease (CAD) — later found to have been triggered by a previous COVID-19 infection —…
A new case study reports the rare co-occurrence of cold agglutinin disease (CAD) and blood cancer in a man…
A woman developed cold agglutinin disease (CAD), with high levels of cold agglutinins sustained for four months after…
Cold agglutinin disease (CAD) patients who take Enjaymo (sutimlimab-jome) long term may continue to experience disease remission after…
Fatigue is one of the most common symptoms of cold agglutinin disease (CAD), affecting 90% of patients, a U.S.
A total of 30 patient advocacy groups working to further understanding and the needs of people living with rare diseases…
A middle-aged woman’s suddenly black fingertips and dark urine were telltale symptoms that she had developed cold…
A 71-year-old woman with primary cold agglutinin disease (CAD) was successfully treated with the glucocorticoid prednisone, a case study…
To help patients and families in the U.S. facing out-of-pocket medical costs, The Assistance Fund (TAF) has opened a new program…